Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Buy
68
ENFN Quote, Financials, Valuation and Earnings
Last price:
$11.08
Seasonality move
:
-12.46%
Day range:
$11.02 - $11.10
52-week range:
$7.83 - $11.80
Dividend yield:
0%
P/E ratio:
369.67x
P/S ratio:
6.57x
P/B ratio:
14.36x
Volume:
804.3K
Avg. volume:
1.1M
1-year change:
22%
Market cap:
$1.1B
Revenue:
$201.6M
EPS (TTM):
$0.03
Earnings Data
Next earnings date for ENFN
May 09
2025
Most recent earnings per share
--
Missed by $0.06
(Mar 3/2025)
Consensus Estimate
$0.06
(Mar 3/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ENFN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/09/2025 | Q1 | $55.1M | -- | -- | $0.06 | -- |
| 03/03/2025 | Q4 | $54.4M | $52.9M | -- | $0.06 | -- |
| 11/04/2024 | Q3 | $52.2M | $51.2M | $0.02 | $0.06 | -$0.04 |
| 08/06/2024 | Q2 | $50M | $49.5M | $0.02 | $0.06 | -$0.04 |
| 05/09/2024 | Q1 | $47.6M | $48.1M | -$0.01 | $0.04 | -$0.05 |
| 03/12/2024 | Q4 | $45.1M | $46.5M | $0.01 | $0.05 | -$0.04 |
| 11/07/2023 | Q3 | $44M | $44.4M | $0.02 | $0.05 | -$0.03 |
| 08/08/2023 | Q2 | $44.6M | $42.7M | $0.01 | $0.04 | -$0.03 |
| 05/09/2023 | Q1 | $40.9M | $41M | $0.04 | $0.03 | $0.01 |
| 03/07/2023 | Q4 | $40M | $40.5M | $0.01 | $0.03 | -$0.02 |
| 11/10/2022 | Q3 | -- | $39.2M | $0.02 | -- | -- |
| 08/09/2022 | Q2 | -- | $36.5M | -$0.03 | -- | -- |
| 05/12/2022 | Q1 | -- | $34.1M | -$0.10 | -- | -- |
| 03/24/2022 | Q4 | -- | $31.9M | -$2.26 | -- | -- |
| 12/02/2021 | Q3 | -- | $29M | $0.05 | -- | -- |
| 06/30/2021 | Q2 | -- | $26.4M | $0.07 | -- | -- |
| 03/31/2021 | Q1 | -- | $24.4M | $0.06 | -- | -- |
| 12/31/2020 | Q4 | -- | $22.7M | -$0.19 | -- | -- |
| 09/30/2020 | Q3 | -- | $19.8M | $0.09 | -- | -- |
Enfusion Earnings Questions
-
How Much did Enfusion Generate in Revenue Last Quarter?
Enfusion reported $52.9M worth of top line sales in its most recent quarter.
-
Did Enfusion Beat Earnings Last Quarter?
Enfusion announced earnings per share of -- which represents a miss of analyst forecast a $0.06 per share.
-
Is Enfusion Profitable?
Enfusion reported $36.5M that represents $0.28 per share over the last quarter.
-
What is the Analyst Consensus for Enfusion EPS Next Year?
Enfusion's earnings are forecast to grow from $0.03 per share to $0.21 per share next year representing an increase of 875.47%.
-
When is Enfusion's Earnings Date?
Enfusion's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 9.23% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 6.65% over the past day.
Buy
93
ESLT alert for Mar 19
Elbit Systems [ESLT] is up 0.6% over the past day.
